Chemical Structure : JNJ-7706621
CAS No.: 443797-96-4
货号: PC-42527Not For Human Use, Lab Use Only.
JNJ-7706621 is a potent, dual CDK/Aurora kinase inhibitor with IC50 of 9/4/11/15 nM for CDK1/CDK2/Aurora A/Aurora B respectively.
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
10 mg | ¥1880 | In stock | |
25 mg | ¥2980 | In stock | |
50 mg | ¥4880 | In stock | |
100 mg | Get quote |
大包装,大折扣!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
JNJ-7706621 is a potent, dual CDK/Aurora kinase inhibitor with IC50 of 9/4/11/15 nM for CDK1/CDK2/Aurora A/Aurora B respectively.
JNJ-7706621 also exhibits activity towards CDK3, CDK4, and CDK6 (IC50s=50-250 nM), and no activity for Plk1 or Wee1.
JNJ-7706621 arrests the cell cycle at the G2-M phase.
JNJ-7706621 shows significant antitumor activity in tumor xenograft model.
分子量 | 394.356 | |
分子式 | C15H12F2N6O3S | |
外观性状 | Solid | |
储存条件 |
|
|
Solubility |
10 mM in DMSO |
|
Chemical Name/SMILES |
Benzenesulfonamide, 4-[[5-amino-1-(2,6-difluorobenzoyl)-1H-1,2,4-triazol-3-yl]amino]- |
1. Emanuel S, et al. Cancer Res. 2005 Oct 1;65(19):9038-46.
2. Huang S, et al. Bioorg Med Chem Lett. 2006 Jul 15;16(14):3639-41.
3. Seamon JA, et al. Mol Cancer Ther. 2006 Oct;5(10):2459-67.
备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright